Uncategorized

Aerpio Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference

by Business Wire • 2018/03/15 • 0 Comments

CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that President and Founder, Joseph Gardner, Ph.D., will present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018 at 8:00 a.m. Eastern Time in New York, N.Y. Dr. Gardner will provide a corporate overview and business update. The presentation will be webcast live and may be accessed b

Full Story →

← Researchers build better AI algorithms to screen patients for diabetic eye disease

Avedro Announces Agreement with the FDA for the First U.S. Pivotal Phase 3 Trial of an Epi-on Cross-Linking Treatment for Patients with Progressive Keratoconus →

Post navigation